Aprea Therapeutics Stock (NASDAQ: APRE) stock price, news, charts, stock research, profile.
Open | $2.99 |
Close | $3.13 |
Volume / Avg. | 22.27K / 9.03K |
Day Range | $2.93 - $3.13 |
52 Wk Range | 2.86 - 8.85 |
Market Cap | $17.00M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 0.27% |
Days to Cover | 2.4 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aprea Therapeutics (NASDAQ:APRE) through any online brokerage.
Other companies in Aprea Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Imunon (NASDAQ:IMNN) and Monopar Therapeutics (NASDAQ:MNPR).
Aprea Therapeutics has a consensus price target of $10.60.
The stock price for Aprea Therapeutics (NASDAQ: APRE) is $3.13 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Aprea Therapeutics.
Aprea Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Aprea Therapeutics.
Aprea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.